More than 5-year islet allograft function in insulin-dependent diabetes mellitus

Transplantation Proceedings

Volumn 29, Issue 4, 1997, Pages 2229-2230

  Alejandro, R ^a   Angelico, M C ^b   Ricordi, C ^b   Burke, G ^b   Nery, J ^b   Miller, J ^b   Esquenazi, V ^b   Mintz, D H ^b  

^a DIABETES RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; HEMOGLOBIN A1C; INSULIN;

ALLOGRAFT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; REFERENCE VALUES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030916722     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(97)00310-2     Document Type: Conference Paper

References (5)

1. Ricordi C, Lacy PE, Finke EH, Olack, et al: Diabetes 37:413, 1988
2. Islet Transplant Registry, Newsletter No 5, Vol 4 (No 1), 1994
3. Ricordi C: Diabetes Rev 4:356, 1996
4. Alejandro R, Burke G, Shapiro ET, et al: Diab Nutr Metab 5(suppl 1):183, 1992
5. DCCT Research Group: N Engl J Med 329:977, 1993